Ligand Pharmaceuticals Incorporated · NASDAQ:LGND

Espinoza Octavio exercised options for 1,736 Ligand Pharmaceuticals Incorporated shares (Form 4)

Traded May 27, 2026 · Filed May 28, 2026

On May 27, 2026, Espinoza Octavio (Chief Financial Officer) exercised options for 1,736 Ligand Pharmaceuticals Incorporated shares at an average US$57.58 for US$99,966, leaving 27,679 shares. Filed May 28, 2026 (Form 4).

Options exercised
1,736 shares
Price
US$57.58 average (US$52.84 to US$63.62)
Value
US$99,966
Holding after
27,679 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 27, 2026Common StockOption exercise764US$63.6226,707Direct
May 27, 2026Common StockOption exercise972US$52.8427,679Direct

Source

View original at SEC

Related